|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent COGT insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why COGT insider buys are important for investors to follow.
Date | Insider | Price | Amount |
6-9-2023 Insider Buy |
Fairmount Funds Management LLC >10% Owner |
$12.00
CAGR »
|
$9,600,000.00 800,000 shares |
6-16-2022 Insider Buy |
Fairmount Funds Management LLC >10% Owner |
$8.25
CAGR »
|
$9,900,000.00 1,200,000 shares |
3-29-2018 Insider Buy |
Ryan Schulke Chief Executive Officer |
$2.54
CAGR »
|
$254,000.00 100,000 shares |
3-29-2018 Insider Buy |
Matthew Conlin President |
$2.54
CAGR »
|
$101,579.00 40,000 shares |
3-28-2018 Insider Buy |
Ryan Schulke Chief Executive Officer |
$2.58
CAGR »
|
$258,000.00 100,000 shares |
2-15-2018 Insider Buy |
Jeffrey Alan Dell Chief Information Officer |
$3.10
CAGR »
|
$6,200.00 2,000 shares |
2-13-2018 Insider Buy |
Michael Brauser Director |
$2.85
CAGR »
|
$57,000.00 20,000 shares |
2-13-2018 Insider Buy |
Matthew Conlin >10% Owner |
$2.81
CAGR »
|
$56,200.00 20,000 shares |
2-13-2018 Insider Buy |
Ryan Schulke Director and >10% Owner |
$2.93
CAGR »
|
$293,000.00 100,000 shares |
12-15-2017 Insider Buy |
Michael Brauser Director |
$3.65
CAGR »
|
$65,610.00 18,000 shares |
12-14-2017 Insider Buy |
Daniel Maclachlan Chief Financial Officer |
$3.74
CAGR »
|
$1,870.00 500 shares |
12-14-2017 Insider Buy |
Derek Dubner Chief Executive Officer |
$3.73
CAGR »
|
$3,730.00 1,000 shares |
12-13-2017 Insider Buy |
Michael Brauser Director |
$3.83
CAGR »
|
$3,825.00 1,000 shares |
12-8-2017 Insider Buy |
Phillip Frost, M.D et. al. Director and >10% Owner |
$3.95
CAGR »
|
$39,500.00 10,000 shares |
12-8-2017 Insider Buy |
Michael Brauser Director |
$3.99
CAGR »
|
$9,975.00 2,500 shares |
12-5-2017 Insider Buy |
Michael Brauser Director |
$4.00
CAGR »
|
$20,148.00 5,037 shares |
12-1-2017 Insider Buy |
Michael Brauser Director |
$4.18
CAGR »
|
$14,630.00 3,500 shares |
11-17-2017 Insider Buy |
Jeffrey Alan Dell Chief Information Officer |
$3.95
CAGR »
|
$15,800.00 4,000 shares |
11-16-2017 Insider Buy |
Michael Brauser Executive Chairman |
$4.06
CAGR »
|
$15,008.00 3,700 shares |
11-15-2017 Insider Buy |
Michael Brauser Executive Chairman |
$4.09
CAGR »
|
$30,650.00 7,500 shares |
11-15-2017 Insider Buy |
Phillip Frost, M.D et. al. Director and >10% Owner |
$4.11
CAGR »
|
$82,200.00 20,000 shares |
11-13-2017 Insider Buy |
Michael Brauser Executive Chairman |
$4.25
CAGR »
|
$40,790.00 9,600 shares |
3-28-2017 Insider Buy |
Michael Brauser Executive Chairman |
$4.40
CAGR »
|
$4,400.00 1,000 shares |
3-22-2017 Insider Buy |
Michael Brauser Executive Chairman |
$3.42
CAGR »
|
$23,940.00 7,000 shares |
3-22-2017 Insider Buy |
Harry Baker Jordan III Chief Operating Officer |
$3.39
CAGR »
|
$33,900.00 10,000 shares |
3-22-2017 Insider Buy |
Derek Dubner Chief Executive Officer |
$3.39
CAGR »
|
$3,390.00 1,000 shares |
3-22-2017 Insider Buy |
Jeffrey Alan Dell Chief Information Officer |
$3.40
CAGR »
|
$6,800.00 2,000 shares |
3-21-2017 Insider Buy |
Michael Brauser Executive Chairman |
$3.50
CAGR »
|
$24,500.00 7,000 shares |
3-14-2017 Insider Buy |
Michael Brauser Executive Chairman |
$3.60
CAGR »
|
$18,000.00 5,000 shares |
3-14-2017 Insider Buy |
Derek Dubner Chief Executive Officer |
$3.59
CAGR »
|
$3,590.00 1,000 shares |
3-14-2017 Insider Buy |
Harry Baker Jordan III Chief Operating Officer |
$3.60
CAGR »
|
$144,000.00 40,000 shares |
1-26-2017 Insider Buy |
Ryan Schulke Director and >10% Owner |
$3.95
CAGR »
|
$59,250.00 15,000 shares |
1-20-2017 Insider Buy |
Robert Swayman Director |
$3.12
CAGR »
|
$156,000.00 50,000 shares |
1-23-2017 Insider Buy |
Matthew Conlin >10% Owner |
$3.15
CAGR »
|
$315,000.00 100,000 shares |
1-23-2017 Insider Buy |
Ryan Schulke Director and >10% Owner |
$3.15
CAGR »
|
$472,500.00 150,000 shares |
11-30-2016 Insider Buy |
Michael Brauser Executive Chairman |
$3.35
CAGR »
|
$10,050.00 3,000 shares |
11-30-2016 Insider Buy |
Harry Baker Jordan III Chief Operating Officer |
$3.25
CAGR »
|
$16,250.00 5,000 shares |
11-29-2016 Insider Buy |
Ryan Schulke Director and >10% Owner |
$3.79
CAGR »
|
$7,580.00 2,000 shares |
11-29-2016 Insider Buy |
Michael Brauser Executive Chairman |
$3.71
CAGR »
|
$12,985.00 3,500 shares |
11-9-2016 Insider Buy |
Matthew Conlin >10% Owner |
$3.73
CAGR »
|
$18,650.00 5,000 shares |
11-9-2016 Insider Buy |
Ryan Schulke Director and >10% Owner |
$3.72
CAGR »
|
$18,600.00 5,000 shares |
11-9-2016 Insider Buy |
Michael Brauser Executive Chairman |
$3.69
CAGR »
|
$18,450.00 5,000 shares |
11-8-2016 Insider Buy |
Ryan Schulke Director and >10% Owner |
$4.01
CAGR »
|
$20,050.00 5,000 shares |
11-8-2016 Insider Buy |
Matthew Conlin >10% Owner |
$4.01
CAGR »
|
$20,050.00 5,000 shares |
11-8-2016 Insider Buy |
Michael Brauser Executive Chairman |
$3.79
CAGR »
|
$24,635.00 6,500 shares |
11-7-2016 Insider Buy |
Harry Baker Jordan III Chief Operating Officer |
$3.97
CAGR »
|
$615,550.00 155,000 shares |
11-7-2016 Insider Buy |
Robert N. Fried Director |
$3.75
CAGR »
|
$7,500.00 2,000 shares |
11-7-2016 Insider Buy |
Jeffrey Alan Dell Chief Information Officer |
$3.20
CAGR »
|
$6,400.00 2,000 shares |
11-7-2016 Insider Buy |
Robert Swayman Director |
$3.68
CAGR »
|
$36,800.00 10,000 shares |
11-7-2016 Insider Buy |
Ryan Schulke Director and >10% Owner |
$3.51
CAGR »
|
$72,583.29 20,679 shares |
11-7-2016 Insider Buy |
Derek Dubner Chief Executive Officer |
$3.66
CAGR »
|
$10,965.60 3,000 shares |
11-7-2016 Insider Buy |
Matthew Conlin >10% Owner |
$3.51
CAGR »
|
$76,560.12 21,812 shares |
11-7-2016 Insider Buy |
Daniel Maclachlan Chief Financial Officer |
$3.45
CAGR »
|
$3,449.90 1,000 shares |
11-7-2016 Insider Buy |
Michael Brauser Executive Chairman |
$3.64
CAGR »
|
$65,462.40 18,000 shares |
11-7-2016 Insider Buy |
Phillip Frost, M.D et. al. Director and >10% Owner |
$3.17
CAGR »
|
$111,050.00 35,000 shares |
10-25-2016 Insider Buy |
Phillip Frost, M.D et. al. Director and >10% Owner |
$3.42
CAGR »
|
$17,103.00 5,000 shares |
10-19-2016 Insider Buy |
Phillip Frost, M.D et. al. Director and >10% Owner |
$3.46
CAGR »
|
$86,550.00 25,000 shares |
Also See: Institutional Holders of COGT
Also See: SEC filings
Below we present the annualized performance delivered by COGT stock since 6-9-2023 (the date of the most recent
insider purchase). The performance of the investment from the time COGT insider buying occurred is the ultimate
test of whether insiders were right about COGT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/12/2023 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$12.25 |
|
End price/share: |
$7.12 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-41.88% |
|
Annualized Gain: |
-48.52% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,812.00 |
|
Years: |
0.86 |
|
COGT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent COGT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding COGT
|
|